Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1991 2
1992 2
1993 2
1994 2
1995 2
1997 2
1999 4
2000 5
2001 1
2005 1
2008 1
2009 1
2015 2
2016 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster.
Tiru M, Hallander HO, Gustafsson L, Storsaeter J, Olin P. Tiru M, et al. Vaccine. 2000 Apr 28;18(21):2295-306. doi: 10.1016/s0264-410x(99)00539-3. Vaccine. 2000. PMID: 10717350 Clinical Trial.
Data from two Swedish pertussis vaccine trials with various combination vaccines were used to compare anti-diphtheria antitoxin concentrations over time between different vaccines, vaccine lots and vaccine schedules. ...The latter schedule gave significantly higher …
Data from two Swedish pertussis vaccine trials with various combination vaccines were used to compare anti-diphtheria antitoxin …
Circulating diphtheria antitoxin levels in children aged 11-14 years in relation to the vaccinal history.
Ajello F, Lampiasi AM, Candido G, D'Angelo C. Ajello F, et al. Vaccine. 1991 Jul;9(7):502-4. doi: 10.1016/0264-410x(91)90036-6. Vaccine. 1991. PMID: 1897306 Clinical Trial.
Diphtheria antitoxin level in serum samples obtained from 204 healthy children aged 11-14 years was determined by means of an indirect haemagglutination technique and related to the vaccinal history of the subjects. ...No significant decrease in mean antitoxin …
Diphtheria antitoxin level in serum samples obtained from 204 healthy children aged 11-14 years was determined by means of an …
[Diphtheria antitoxin level 2 years after booster vaccination].
Nicolay U, Girgsdies OE, Banzhoff A, Hundt E, Kondler-Budde R, Lober R, Hainz R, Jilg W. Nicolay U, et al. Wien Med Wochenschr. 2000;150(22):435-9. Wien Med Wochenschr. 2000. PMID: 11191952 Clinical Trial. German.
Both short-term and long-term immunogenicity was assessed by determining diphtheria antitoxin levels four weeks after vaccination and after one and two years. 102 subjects received the first booster vaccination, and 83 were vaccinated twice. Prior to the first vacci …
Both short-term and long-term immunogenicity was assessed by determining diphtheria antitoxin levels four weeks after vaccinat …
Vaccines for women for preventing neonatal tetanus.
Demicheli V, Barale A, Rivetti A. Demicheli V, et al. Cochrane Database Syst Rev. 2015 Jul 6;2015(7):CD002959. doi: 10.1002/14651858.CD002959.pub4. Cochrane Database Syst Rev. 2015. PMID: 26144877 Free PMC article.
Tetanus toxoid consists of a formaldehyde-treated toxin that stimulates the production of antitoxin. OBJECTIVES: To assess the effectiveness of tetanus toxoid, administered to women of reproductive age or pregnant women, to prevent cases of, and deaths from, neonatal tetan …
Tetanus toxoid consists of a formaldehyde-treated toxin that stimulates the production of antitoxin. OBJECTIVES: To assess the effect …
Diphtheria booster vaccination: one or two injections?
Nicolay U, Girgsdies OE, Banzhoff A, Hundt E, Jilg W. Nicolay U, et al. Vaccine. 1999 May 4;17(18):2223-8. doi: 10.1016/s0264-410x(99)00013-4. Vaccine. 1999. PMID: 10403589 Clinical Trial.
The geometric mean diphtheria antitoxin concentration after the first booster (day 28) was 2.354 I.U./ml, and after the second booster (day 56) 2.238 I.U....Prior to the first vaccination 48.9% of the subjects had a diphtheria antitoxin level below 0.1 …
The geometric mean diphtheria antitoxin concentration after the first booster (day 28) was 2.354 I.U./ml, and after the second …
Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to standard-dose diphtheria, tetanus, acellular pertussis when used as a pre-school booster in UK children: A 5-year follow-up of a randomised controlled study.
John T, Voysey M, Yu LM, McCarthy N, Baudin M, Richard P, Fiquet A, Kitchin N, Pollard AJ. John T, et al. Vaccine. 2015 Aug 26;33(36):4579-85. doi: 10.1016/j.vaccine.2015.06.105. Epub 2015 Jul 10. Vaccine. 2015. PMID: 26165918 Free article. Clinical Trial.
This serological follow up study assessed the kinetics of antibody response in children who previously participated in a single centre, open-label, randomised controlled trial of low-dose compared to standard-dose diphtheria booster preschool vaccinations in the United Kin …
This serological follow up study assessed the kinetics of antibody response in children who previously participated in a single centre, open …
Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children.
Scheifele DW, Meekison W, Grace M, Barreto L, Carter AO, Mitchell L, Farley J. Scheifele DW, et al. CMAJ. 1991 Sep 15;145(6):641-7. CMAJ. 1991. PMID: 1893319 Free PMC article. Clinical Trial.
Serum samples obtained before vaccination were tested for diphtheria and tetanus antitoxin levels by means of neutralization assay and enzyme-linked immunosorbent assay. ...In the former group large erythematous reactions occurred significantly more often in those w …
Serum samples obtained before vaccination were tested for diphtheria and tetanus antitoxin levels by means of neutralization a …
Prevalence of diphtheria toxin antibodies in human sera from a cross-section of the Italian population.
Bergamini M, Comodo N, Gasparini R, Gabutti G, Fabrizi P, Severini R, Ajello F, Bonanni P, Castagnari L, Cocchioni M, Della Pietra P, Fragapane E, Grilli A, Liberatore S, Lo Nostro A, Moiraghi-Ruggenini A, Pellegrini MG, Pozzi T, Tarsitani G, Zotti C, Crovari P. Bergamini M, et al. Vaccine. 1999 Jan 21;17(3):286-90. doi: 10.1016/s0264-410x(98)00053-x. Vaccine. 1999. PMID: 9987165 Clinical Trial.
To determine diphtheria antitoxin, sera from 5187 apparently healthy subjects, divided according to sex and age groups, were titrated using an ELISA indirect method. A basic protective titre of diphtheria antitoxin (> 0.01 IU ml-1) was found in 4080 …
To determine diphtheria antitoxin, sera from 5187 apparently healthy subjects, divided according to sex and age groups, were t …
Revaccination of adults against diphtheria. II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination.
Simonsen O, Klaerke M, Klaerke A, Bloch AV, Hansen BR, Hald N, Hau C, Heron I. Simonsen O, et al. Acta Pathol Microbiol Immunol Scand C. 1986 Oct;94(5):219-25. doi: 10.1111/j.1699-0463.1986.tb02115.x. Acta Pathol Microbiol Immunol Scand C. 1986. PMID: 3565028 Clinical Trial.
Side-reactions were recorded one week later, and antitoxin response was assessed after 4 weeks. Protective serum diphtheria antitoxin levels were attained by all subjects receiving diphtheria toxoid containing vaccines. Antibody response was related to …
Side-reactions were recorded one week later, and antitoxin response was assessed after 4 weeks. Protective serum diphtheria …
Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
Halperin SA, King J, Law B, Mills E, Willems P. Halperin SA, et al. Clin Infect Dis. 1999 May;28(5):995-1001. doi: 10.1086/514741. Clin Infect Dis. 1999. PMID: 10452624 Clinical Trial.
The purpose of this randomized, controlled trial was to assess the safety and immunogenicity of a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine given either separately or combined as a single inj …
The purpose of this randomized, controlled trial was to assess the safety and immunogenicity of a three-component acellular pertussis vaccin …
29 results